Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression.
Animals
Clostridiales
/ physiology
Diet, High-Fat
/ adverse effects
Dietary Fats, Unsaturated
/ metabolism
Fatty Acids
/ metabolism
Feces
/ microbiology
Gastrointestinal Microbiome
/ physiology
Lipid Metabolism
/ physiology
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Obesity
/ metabolism
Prostatic Neoplasms
/ metabolism
Weight Gain
/ physiology
gut microbiota
lipid metabolism
monounsaturated fatty acid
prostate cancer
saturated fatty acid
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
17 Feb 2022
17 Feb 2022
Historique:
received:
17
11
2021
revised:
29
01
2022
accepted:
08
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
29
3
2022
Statut:
epublish
Résumé
Lard diet (LD) is a risk factor for prostate cancer (PCa) development and progression. Two immunocompetent mouse models fed with isocaloric specific fat diets (LD) enriched in saturated and monounsaturated fatty acid (SMFA), showed significanftly enhanced PCa progression with weight gain compared with a fish oil diet (FOD). High gut microbial divergency resulted from difference in diets, and the abundance of several bacterial species, such as in the orders Clostridiales and Lactobacillales, was markedly altered in the feces of LD- or FOD-fed mice. The proportion of the order Lactobacillales in the gut was negatively involved in SMFA-induced body weight gain and PCa progression. We found the modulation of lipid metabolism and cholesterol biosynthesis pathways with three and seven commonly up- and downregulated genes in PCa tissues, and some of them correlated with the abundance of the order Lactobacillales in mouse gut. The expression of sphingosine 1-phosphate receptor 2, which is associated with the order Lactobacillales and cancer progression in mouse models, was inversely associated with aggressive phenotype and weight gain in patients with PCa using the NCBI Gene Expression Omnibus database. Therefore, SMFA may promote PCa progression with the abundance of specific gut microbial species and overexpression of lipogenic genes in PCa. Therapeutics with alteration of gut microbiota and candidate genes involved in diet-induced PCa progression may be attractive in PCa.
Identifiants
pubmed: 35216332
pii: ijms23042214
doi: 10.3390/ijms23042214
pmc: PMC8878430
pii:
doi:
Substances chimiques
Dietary Fats, Unsaturated
0
Fatty Acids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Mol Cell Proteomics. 2016 Jan;15(1):154-63
pubmed: 26545398
Nat Rev Urol. 2010 Aug;7(8):442-53
pubmed: 20647991
Nature. 2000 Oct 26;407(6807):1007-11
pubmed: 11069180
Cancer Res. 2021 Aug 1;81(15):4014-4026
pubmed: 34039634
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):930-7
pubmed: 18398033
Cell. 2016 Dec 15;167(7):1897
pubmed: 27984736
Cell Metab. 2015 Oct 6;22(4):658-68
pubmed: 26321659
Subcell Biochem. 2008;49:387-412
pubmed: 18751920
J Lipid Res. 2016 Mar;57(3):333-5
pubmed: 26798145
Prostate Cancer Prostatic Dis. 2018 Nov;21(4):539-548
pubmed: 29988102
Front Oncol. 2021 Jun 17;11:679712
pubmed: 34221998
Gut. 2019 Aug;68(8):1417-1429
pubmed: 30782617
J Natl Cancer Inst. 1995 Oct 4;87(19):1456-62
pubmed: 7545759
Clin Cancer Res. 2003 Jul;9(7):2734-43
pubmed: 12855654
Nutr Res Rev. 2010 Dec;23(2):270-99
pubmed: 20977819
PLoS Biol. 2003 Dec;1(3):E59
pubmed: 14691534
Obesity (Silver Spring). 2007 Apr;15(4):798-808
pubmed: 17426312
Cancer Res. 1997 Aug 15;57(16):3325-30
pubmed: 9269988
Am J Cancer Res. 2011;1(4):460-81
pubmed: 21984966
Liver Res. 2019 Mar;3(1):19-24
pubmed: 31360579
Arch Microbiol. 2021 Apr;203(3):1221-1229
pubmed: 33620523
Nutr Metab (Lond). 2019 Apr 11;16:24
pubmed: 31011360
Science. 2021 Oct 8;374(6564):216-224
pubmed: 34618582
Sci Rep. 2019 Sep 13;9(1):13257
pubmed: 31520002
Int J Mol Sci. 2021 Jul 28;22(15):
pubmed: 34360839
J Urol. 2010 Apr;183(4):1619-24
pubmed: 20172549
Pharmacol Res. 2022 Jan;175:106020
pubmed: 34896249
Nat Genet. 2018 Feb;50(2):206-218
pubmed: 29335545
Benef Microbes. 2021 Jun 15;12(3):239-248
pubmed: 33789551
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):697-707
pubmed: 23549401
Prostate. 2008 Feb 15;68(3):321-35
pubmed: 18175332
J Clin Med. 2019 Apr 30;8(5):
pubmed: 31052319
Nat Med. 2016 Oct 06;22(10):1079-1089
pubmed: 27711063
Nature. 2016 Jul 06;535(7610):65-74
pubmed: 27383981
Metabolites. 2021 Jan 15;11(1):
pubmed: 33467644
Yale J Biol Med. 2012 Mar;85(1):19-28
pubmed: 22461740
Eur Urol. 2018 Nov;74(5):575-582
pubmed: 30007819
Sci Rep. 2021 Mar 18;11(1):6367
pubmed: 33737543
Eur Urol. 2013 May;63(5):800-9
pubmed: 23219374
Obesity (Silver Spring). 2017 Nov;25(11):1932-1940
pubmed: 28944626
Oncogenesis. 2016 Feb 15;5:e195
pubmed: 26878389
Lab Invest. 2017 Jan;97(1):4-13
pubmed: 27869795
Am J Pathol. 2010 Dec;177(6):3180-91
pubmed: 21088217
FEBS J. 2013 Dec;280(24):6354-66
pubmed: 23879641
J Cell Physiol. 2018 Sep;233(9):7367-7378
pubmed: 29663374
Clin Cancer Res. 2018 Sep 1;24(17):4309-4318
pubmed: 29776955
Mech Dev. 2001 Mar;101(1-2):61-9
pubmed: 11231059
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Front Pharmacol. 2018 Dec 06;9:1345
pubmed: 30574087
Appl Environ Microbiol. 2006 Feb;72(2):1027-33
pubmed: 16461645
J Clin Biochem Nutr. 2019 Jul;65(1):34-46
pubmed: 31379412